Obviously theres new drugs that are coming, new mechanisms, the GLP-1s, GIP, that really is going to continue to evolve and shift the game. The US Food and Drug Administration recently approved the Wegovy GLP-1 oral pill in December 2025
I've never pulled the trigger on one myself, and I'm not even sure I've seen one ordered by endocrinology at least not in the past 5 years, I don't think
Distribution Channel Analysis The hospital pharmacies segment grew at a substantial rate, generating a revenue portion of 57.8% as hospitals are key centers for the diagnosis and management of type 2 diabetes and obesity, often initiating treatment with GLP-1 receptor agonists
Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1r) in the rat brain
This is why it is increasingly being explored in: Longevity medicine Functional medicine Regenerative aesthetics Hair restoration medicine Sports recovery Healthy aging protocols GHK-Cu and Collagen Production One of the most extensively studied benefits of GHK-Cu is its effect on collagen synthesis
Glutathione is a small but mighty antioxidant that works hard to protect the body against oxidative stress